{"id":"tp-30562","type":"article-newspaper","title":"Nurix Therapeutics Reports $4.73 Q3 GAAP EPS and $673.1M Revenue","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/30562","datePublished":"2026-10-12T20:14:15.000Z","dateModified":"2026-10-12T20:14:15.000Z","language":"en","abstract":"Revenue rose 8,420.3% from a year earlier and exceeded estimates by $193.58 million. Cash, cash equivalents and marketable securities totaled $1.1 billion as of Aug. 31, 2026.","section":"Business","references":[]}